This site is intended for healthcare professionals only
LoginRegister
SEC Recommends Market Authorization for Elobixibat 5 mg Tablets by Exemed PharmaExemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture Market Antidiabetic FDC
Unichem Labs Roha facility gets 3 USFDA observationsAlembic Pharma gets one procedural observation for Vadodara facility
Setback To Novartis: CDSCO Panel Rejects Lanalumab Phase III Trial Design Over Study FlawsNovartis Gets CDSCO Panel Nod To Study Antiparasitic drug LXE408
Zydus Lifesciences venture capital arm invests in Feldan TherapeuticsLaurus Labs to invest Rs 83 crore in KRKA Pharma
Eris Gets CDSCO Panel Nod To Dapagliflozin-Bisoprolol-Sacubitril Valsartan Combo Kit, Phase IV Trial MandatedEris Lifesciences transfers 100% stake in 2 arms to Eris Therapeutics for Rs 861.9 crore
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag InternationalJnJ to discontinue Phase 3 VENTURA development program evaluating aticaprant for major depressive...
AstraZeneca Imfinzi approved in EU as immunotherapy for limited stage small cell lung cancerCDSCO nod to AstraZeneca to import, sell hyperkalaemia treatment drug in India
Biocon Biologics, Civica join hands to expand Insulin Aspart access in USBiocon Biologics, Civica join hands to expand Insulin Aspart access in US
NPPA fixes retail prices of 53 formulations, DetailsNPPA fixes retail prices of 53 formulations, Details
Roche Susvimo maintains vision over five years with two refills per year in people with nAMDConduct Phase III CT in Indian population: CDSCO Panel tells Roche Products India on Baloxavir...
Pfizer loses patent lawsuit to SK Bioscience over Pneumococcal VaccinePatent infringement: Pfizer convinces US Patent Office to cancel two Moderna coronavirus vaccine...
Merck injected version of Keytruda faces possible patent challenge: ReportMerck injected version of Keytruda faces possible patent challenge: Report
X